If you’re looking for pullbacks in the cannabis space with interesting technical features, you could do a lot worse than CannaRoyalty Corp (OTCMKTS:ORHOF). The stock has dropped about 48% in the past 6 weeks but just caught some key support at a rising 200-day simple moving average. To help flesh out that picture, the company just announced that the new objective is to grow the fund to $1 million over the next four years.

Aphria (TSX:APHA)(NYSE:APHA) has been dominating the headlines for all the wrong reasons of late. With the stock now down 63% from its high, you can bet that contrarian “bargain hunters” (more like cigar-butt marijuana traders) have been placing their bets on the badly bruised pot stock with the hopes of realizing massive upside over the near term.

While this massive short-term upside potential exists (Aphria stock could easily triple), I think such an explosive move is contingent on the occurrence of two events, neither of which have a high probability of happening over the next year.

After a long wait, Vancouver-based AgraFlora finally received a cultivation license from Health Canada in October for the AAA Heidelberg facility, in London, Ontario, of which AgraFlora currently owns 56 per cent. In addition to Heidelberg, AgraFlora also runs a 2.2-million sq. ft. cannabis propagation greenhouse in Delta, BC, and is a member of industry heavyweight Canopy Growth Corp’s “CraftGrow” program which partners Canopy with smaller, high-quality operations.

AgraFlora President and CEO Derek Ivany says that through the Cannmart deal his company will be helping to supply the highest quality flower to medical marijuana patients across Canada.

It’s been an exciting couple of weeks for the marijuana industry in general and Aurora Cannabis (NYSE:ACB) in particular. This week, Aurora announced a new acquisition in Mexico that sent ACB stock significantly higher.

More than two dozen illegal cannabis dispensaries in Vancouver will have to close their doors, the B.C. Supreme Court has ruled.

The decision announced Thursday applies to all dispensaries named in a suit brought by the City of Vancouver.

So far, 53 injunctions have been filed against marijuana-related businesses operating outside the city's regulations. The city said in a statement that some closed prior to the case being heard in court, but the remaining 28 will now have to cease operations.

Owners who do not close down can face court-ordered fines, jail time or both, the city said.

Aurora Cannabis Inc. has signed a deal to invest $10 million in High Tide Inc., a privately held company with cannabis and cannabis accessory retail stores.

Under the agreement, Aurora will hold debentures that will bear an annual interest rate of 8.5 per cent.

The debentures will also be convertible into shares of High Tide at a price of 75 cents per share. High Tide has four cannabis retail stores in Alberta under the Canna Cabana banner, and a majority stake in KushBar Inc.

It also has plans to open more stores in Alberta as well as expand into Ontario and B.C.

In addition to the retail side, High Tide has two wholesale businesses – Famous Brandz and RGR Canada – and 19 Smoker’s Corner retail locations.

Following the legalization of recreational cannabis in Canada and the recent pullback, all eyes are on profitability and potential within the cannabis industry.

As such, we have identified three Canadian cannabis stocks that have distinguished themselves by posting positive EBITDA and net income in their last quarterly statements. These companies have significantly outperformed their industry peers which, on average, have reported EBITDA losses of $6.53M and net income losses of $5M.

Aphria (TSX:APHA)(NYSE:APHA) is up 60% in the past week, and investors who missed the bottom of the recent sell-off in one of Canada’s top marijuana stocks are wondering if more gains could be on the way.

Let’s take a look at the current situation to see if Aphria deserves to be on your buy list right now.

 If you thought that marijuana stocks were done for the year, you may be finding yourself at a loss for words after the latest industry moves. Not only has the Farm Bill and New York state legalization taken a place on the "breaking marijuana stock news" list this week, so has interest from new investment firms.

Marijuana producer Aphria Inc. (APHA.TO 5.12%) has signed a letter of intent to supply a company in Paraguay with medical cannabis.

Under the agreement, Aphria will supply Insumos Medicos S.A., a pharmaceutical manufacturing, import and distribution company.

Aphria says Insumos will undertake the registration of the Canadian company's products in Paraguay and the appropriate licensing for the import of medical cannabis.

Paraguay will become the Ontario company's third market in Latin America, following Argentina and Colombia.

Aphria has been under pressure in recent days after short-sellers alleged the company bought assets in Colombia, Argentina and Jamaica at "vastly inflated prices."